TME Pharma AG

Industry · 15 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Canc Metastatic Pancreatic Cancer	Phase 2	2026-01-01
Active Not Recruiting	Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients Glioblastoma	Phase 1 / Phase 2	2019-09-12
Completed	Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer	Phase 1 / Phase 2	2017-04-18
Completed	Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients Anemia, End Stage Renal Disease	Phase 1 / Phase 2	2014-05-01
Completed	Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer Anemia of Chronic Disease	Phase 2	2012-09-01
Completed	NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria Type 2 Diabetes Mellitus, Albuminuria	Phase 2	2012-03-01
Completed	NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma Multiple Myeloma	Phase 2	2012-03-01
Completed	NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia	Phase 2	2012-03-01
Completed	Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model Anemia of Chronic Disease	Phase 1	2012-01-01
Completed	First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94 Anemia, Chronic Diseases, Inflammation	Phase 1	2011-07-01
Completed	A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36 Renal Impairment	Phase 1	2011-06-01
Completed	NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers Hematopoietic Stem Cell Transplantation	Phase 1	2010-08-01
Completed	NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus	Phase 1 / Phase 2	2010-07-01
Completed	NOX-A12 First-in-human (FIH) Study Autologous Stem Cell Transplantation	Phase 1	2009-10-01
Completed	NOX-E36 First-in-Human (FIH) Study Chronic Inflammatory Diseases, Type 2 Diabetes Mellitus, Systemic Lupus Erythematosus	Phase 1	2009-05-01